The mechanism of enhanced insulin amyloid fibril formation by NaCl is better explained by a conformational change model

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Muzaffar, Mahvish ^a   Ahmad, Atta ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; GUANIDINE; INSULIN; SODIUM CHLORIDE; THIOFLAVINE; UREA; THIAZOLE DERIVATIVE;

ARTICLE; CHEMICAL REACTION KINETICS; CIRCULAR DICHROISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISSOCIATION; ELUTION; GEL PERMEATION CHROMATOGRAPHY; HORMONE STRUCTURE; INSULIN FIBRILLATION; MOLECULAR MODEL; PH; PROTEIN CONFORMATION; PROTEIN MODIFICATION; PROTEIN STRUCTURE; CHEMICAL STRUCTURE; CHEMISTRY; GEL CHROMATOGRAPHY; HUMAN; KINETICS; METABOLISM; X RAY CRYSTALLOGRAPHY;

AMYLOID; CHROMATOGRAPHY, GEL; CIRCULAR DICHROISM; CRYSTALLOGRAPHY, X-RAY; HUMANS; INSULIN; KINETICS; MODELS, MOLECULAR; PROTEIN CONFORMATION; SODIUM CHLORIDE; THIAZOLES;

EID: 81455125565     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027906     Document Type: Article

References (81)

1. Fink AL, (1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3: R9-23.
2. Chiti F, Dobson CM, (2006) Protein Misfolding, Functional Amyloid, and Human Disease. Annu Rev Biochem 75: 333-336.
3. Sipe JD, Cohen AS, (2000) Review: history of the amyloid fibril. J Struct Biol 130: 88-98.
4. Blake C, Serpell L, (1996) Synchrotron X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 4: 989-998.
5. Burke MJ, Rougvie MA, (1972) Cross-beta protein structures. I. Insulin fibrils. Biochemistry 11: 2435-2439.
6. Glenner GG, (1981) The bases of the staining of amyloid fibers: their physico-chemical nature and the mechanism of their dye-substrate interaction. Prog Histochem Cytochem 13: 1-37.
7. Fändrich M, Fletcher MA, Dobson CM, (2001) Amyloid fibrils from muscle myoglobin. Nature 410: 165-166.
8. Uversky VN, Li J, Souillac P, Millett IS, Doniach S, et al. (2002) Biophysical properties of the synucleins and their propensities to fibrillate: inhibition of alpha-synuclein assembly by beta- and gamma-synucleins. J Biol Chem 277: 11970-11978.
9. Roher AE, Baudry J, Chaney MO, Kuo YM, Stine WB, et al. (2000) Oligomerizaiton and fibril asssembly of the amyloid-beta protein. Biochim Biophys Acta 1502: 31-43.
10. Hasegawa K, Ohhashi Y, Yamaguchi I, Takahashi N, Tsutsumi S, et al. (2003) Amyloidogenic synthetic peptides of beta2-microglobulin-a role of the disulfide bond. Biochem Biophys Res Commun 304: 101-106.
11. Scrocchi LA, Chen Y, Waschuk S, Wang F, Cheung S, et al. (2002) Design of peptide-based inhibitors of human islet amyloid polypeptide fibrillogenesis. J Mol Biol 318: 697-706.
12. Carrell RW, Lomas DA, (1997) Conformational disease. Lancet 3550: 134-138.
13. Soto C, (2001) Protein misfolding and disease; protein refolding and therapy. FEBS Lett 498: 204-207.
14. Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL, (2003) Partially folded intermediates in insulin fibrillation. Biochemistry 42: 11404-11416.
15. Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, et al. (1997) Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis. Nature 385: 787-793.
16. Li J, Uversky VN, Fink AL, (2002) Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. Neurotoxicology 23: 553-567.
17. Munishkina LA, Phelan C, Uversky VN, Fink AL, (2003) Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. Biochemistry 42: 2720-27330.
18. Uversky VN, Li J, Fink AL, (2001) Evidence for a partially folded intermediate in alpha-synuclein fibril formation. j Biol Chem 276: 10737-10744.
19. Souillac PO, Uversky VN, Millett IS, Khurana R, Doniach S, et al. (2002) Elucidation of the molecular mechanism during the early events in immunoglobulin light chain amyloid fibrillation. Evidence for an off-pathway oligomer at acidic pH. J Biol Chem 277: 12666-12679.
20. Munishkina LA, Ahmad A, Fink AL, Uversky VN, (2008) Guiding protein aggregation with macromolecular crowding. Biochemistry 47: 8993-9006.
21. Ahmad A, (2010) DnaK/DnaJ/GrpE of Hsp70 system have differing effects on α-synuclein fibrillation involved in Parkinson's disease. Inter J Biol Macromol 46: 275-279.
22. Ahmad A, Muzaffar M, Ingram VM, (2009) Ca2+, within the physiological concentrations, selectively accelerates Aß42 fibril formation and not Aß40 in vitro. Biochim Biophys Acta 1794: 1536-1547.
23. Waugh DF, Wilhelmson DF, Commerford SL, Sackler ML, (1953) Studies of the Nucleation and Growth Reactions of Selected Types of Insulin Fibrils. JAmChemSoc 75: 2592-2600.
24. Nielsen L, Khurana R, Coats A, Frokjaer S, Brange J, et al. (2001) Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry 40: 6036-6046.
25. Störkel S, Schneider HM, Müntefering H, Kashiwagi S, (1983) Iatrogenic, insulin-dependent, local amyloidosis. Lab Invest 48: 108-111.
26. Dische FE, Wernstedt C, Westermark GT, Westermark P, Pepys MB, et al. (1988) Insulin as an amyloid-fibril protein at sites of repeated insulin injections in a diabetic patient. Diabetologia 31: 158-161.
27. Swift B, (2002) Examination of insulin injection sites: an unexpected finding of localized amyloidosis. Diabet Med 19: 881-882.
28. Sahoo S, Reeves W, DeMay RM, (2003) Amyloid tumor: a clinical and cytomorphologic study. Diagn Cytopathol 28: 325-328.
29. Albert SG, Obadiah J, Parseghian SA, Yadira Hurley M, Mooradian AD, (2007) Severe insulin resistance associated with subcutaneous amyloid deposition. Diabetes Res Clin Pract 75: 374-376.
30. Yumlu S, Barany R, Eriksson M, Röcken C, (2009) Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report. Hum Pathol 40.
31. Shikama Y, Kitazawa J, Yagihashi N, Uehara O, Murata Y, et al. (2010) Localized amyloidosis at the site of repeated insulin injection in a diabetic patient. Intern Med 49: 397-401.
32. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
33. Abel JJ, (1926) Crystalline Insulin. Proc Nat Acad Sci USA 12: 132-136.
34. Blatherwick NR, Bischoff F, Maxwell LC, Berger J, Sahyun M, (1927) studies On Insulin. J Biol Chem 72: 57-89.
35. Krogh A, Axel Marius Hemmingsen. Biochem. J. 1928, 1231-, 1238 (1928) The destructive action of heat on insulin solutions. Biochem J 22: 1231-1238.
36. Waugh DF, (1944) The Linkage of Corpuscular Protein moleculs. I. A Fibrous Modification of Insulin J Am Chem Soc 66: 663.
37. Sluzky V, Klibanov AM, Langer R, (1992) Mechanism of insulin aggregation and stabilization in agitated aqueous solutions. Biotechnol Bioeng 40: 895-903.
38. Brange J, Andersen L, Laursen ED, Meyn G, Rasmussen E, (1997) Toward understanding insulin fibrillation. Journal of Pharmaceutical Sciences 86: 517-525.
39. Klostermeyer H, Humbel RE, (1966) The chemistry and biochemistry of insulin. Angew Chem Int Ed Engl 5: 807-822.
40. Brange J, Langkjoer L, (1993) Insulin structure and stability. Pharm Biotechnol 1993;5:315-50 5: 315-350.
41. Millican RL, Brems DN, (1994) Equilibrium intermediates in the denaturation of human insulin and two monomeric insulin analogs. Biochemistry 33: 1116-1124.
42. Ahmad A, Millett IS, Doniach S, Uversky VN, Fink AL, (2004) Stimulation of insulin fibrillation by urea-induced intermediates. J Biol Chem 279: 14999-15013.
43. Ahmad A, Uversky VN, Hong D, Fink AL, (2005) Early events in the fibrillation of monomeric insulin. J Biol Chem 280: 42669-42675.
44. Hong D-P, Ahmad A, Fink AL, (2006) Fibrillation of Human Insulin A and B Chains. Biochemistry 45: 9342-9353.
45. Naiki H, Higuchi K, Hosokawa M, Takeda T, (1989) Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem 177: 244-249.
46. Nielsen L, Frokjaer S, Carpenter JF, Brange J, (2001) Studies of the structure of insulin fibrils by Fourier transform infrared (FTIR) spectroscopy and electron microscopy. J Pharm Sci 90: 29-37.
47. Strickland EH, (1974) Aromatic contributions to circular dichroism spectra of proteins. CRC Crit Rev Biochem 2: 113-175.
48. Beychok S, (1965) Side-chain optical activity in cystine-containing proteins: circular dichroism studies. Proc Natl Acad Sci USA 53: 999-1006.
49. Bushmarina NA, Kuznetsova IM, Biktashev AG, Turoverov KK, Uversky VN, (2001) Partially folded conformations in the folding pathway of bovine carbonic anhydrase II: a fluorescence spectroscopic analysis. Chembiochem 2: 813-821.
50. Kuznetsova IM, Stepanenko OV, Turoverov KK, Zhu L, Zhou JM, et al. (2002) Unraveling multistate unfolding of rabbit muscle creatine kinase. Biochim Biophys Acta 1596: 138-155.
51. Uversky VN, (2010) Mysterious oligomerization of the amyloidogenic proteins. FEBS J 277: 2940-2953.
52. Debye P, Hückel E, (1923) The theory of electrolytes. I. Lowering of freezing point and related phenomena. Physikalische Zeitschrift 24: 185-206.
53. Gregor HP, Belle J, Marcus RA, (1955) Studies on Ionexchange Resins. XIII. Selectivity Coefficients of Quaternary Base Anion-exchange Resins Toward Univalent Anions. J Am Chem Soc 77: 2713-2719.
54. Gjerde DT, Schmuckler G, Fritz JS, (1980) AnionChromatography with Low-Conductivity Eluents. II. J Chromatogr 187: 35-45.
55. Hofmeister F, (1888) On the understanding of the effects of salts. On regularities in the precipitating effect of salts and their relationship to their physiological behavior. Arch Exp Pathol Pharmakol (Leipzig) 24: 247-260.
56. Collins KD, Washabaugh MW, (1985) The Hofmeister effect and the behaviour of water at interfaces. Quart Rev Biophys 18: 323-422.
57. Baldwin RL, (1996) How Hofmeister Ion Interactions Affect Protein Stability. Biophys J 71: 2056-2063.
58. Raman B, Chatani E, Kihara M, Ban T, Sakai M, et al. (2005) Critical balance of electrostatic and hydrophobic interactions is required for β2-microglobulin amyloid fibril growth and stability. Biochemistry 44: 1288-1299.
59. Pedersen JS, Flink JM, Dikov D, Otzen DE, (2006) Sulfates dramatically stabilize a salt-dependent type of glucagon fibrils. Biophys J 90: 4181-4194.
60. Munishkina LA, Henriques J, Uversky VN, Fink AL, (2004) Role of protein-water interactions and electrostatics in alpha-synuclein fibril formation. Biochemistry 43: 3289-3300.
61. Klement K, Wieligmann K, Meinhardt J, Hortschansky P, Richter W, et al. (2007) Effect of different salt ions on the propensity of aggregation and on the structure of Alzheimer's Aβ(1-40) amyloid fibrils. J Mol Biol 373: 1321-1333.
62. Yeh V, Broering JM, Romanyuk A, Chen B, Chernoff YO, et al. (2010) The Hofmeister effect on amyloid formation using yeast prion protein. Protein Sci 19: 47-56.
63. Jain S, Udgaonkar JB, (2010) Salt induced modulation of the pathway of amyloid fibril formation by mouse prion protein. Biochemistry 49: 7615-7624.
64. Apetri AC, Surewicz WK, (2003) Atypical Effect of Salts on the Thermodynamic Stability of Human Prion Protein. J Biol Chem 278: 22187-22192.
65. Ahmad A, Akhtar MS, Bhakuni V, (2001) Monovalent cation-induced conformational change in glucose oxidase leading to stabilization of the enzyme. Biochemistry 40: 1945-1955.
66. Singh LR, Dar TA, Ahmad F, (2009) Living with urea stress. J Biosei 34: 321-331.
67. Goto Y, Calciano LJ, Fink AL, (1990) Acid-induced folding of proteins. Proc Natl Acad Sci USA 87: 573-577.
68. Gursky O, Li Y, Badger J, Caspar DL, (1992) Monovalent cation binding to cubic insulin crystals. Biophys J 61: 604-611.
69. Dolinsky TJ, Czodrowski P, Li H, Nielsen JE, Jensen JH, et al. (2007) PDB2PQR: Expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Res 35: W522-525.
70. Baker NA, Sept D, Joseph S, Holst MJ, McCammon JA, (2001) Electrostatics of nanosystems: application to microtubules and the ribosome. Proc Natl Acad Sci USA 98: 10037-10041.
71. Tito P, Nettleton EJ, Robinson CV, (2000) Dissecting the hydrogen exchange properties of insulin under amyloid fibril forming conditions: a site-specific investigation by mass spectrometry. J molBiol 303: 267-278.
72. Brange J, Dodson GG, Edwards DJ, Holden PH, Whittingham JL, (1997) A model of insulin fibrils derived from the x-ray crystal structure of a monomeric insulin (despentapeptide insulin). Proteins 27: 507-516.
73. Huang K, Maiti NC, Phillips NB, Carey PR, Weiss MA, (2006) Structure-Specific Effects of Protein Topology on Cross-â Assembly: Studies of Insulin Fibrillation. Biochemistry 45: 10278-10293.
74. Hua QX, Weiss MA., Mechanism of insulin fibrillation: the structure of insulin under amyloidogenic conditions resembles a protein-folding intermediate. J Biol Chem 279: 21449-21460.
75. Ivanova MI, Sievers SA, Sawaya MR, Wall JS, Eisenberg D, (2009) Molecular basis for insulin fibril assembly. Proc Natl Acad Sci USA 106: 18990-18995.
76. Gibson TJ, Murphy RM, (2006) Inhibition of insulin fibrillogenesis with targeted peptides. Protein Sci 15: 1133-1141.
77. Jiménez JL, Nettleton EJ, Bouchard M, Robinson CV, Dobson CM, et al. (2002) The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci USA 99: 9196-9201.
78. Hohenester E, Keller JW, Jansonius JN, (1994) An Alkali Metal Ion Size-Dependent Switch in the Active Site Structure of Dialkylglycine Decarboxylase. Biochemistry 33: 13561-13570.
79. De Bolle X, Vinals C, Fastrez J, Feytmans E, (1997) Bivalent cations stabilize yeast alcohol dehydrogenase I. Biochem J 323: 409-413.
80. Pace CN, Grimsley GR, (1988) Ribonuclease T1 is stabilized by cation and anion binding. Biochemistry 27: 3242-3246.
81. Ferrari D, Diers JR, Bocian DF, Kaarsholm NC, Dunn MF, (2001) Raman signatures of ligand binding and allosteric conformation change in hexameric insulin. Biopolymers 62: 249-160.